VISUDYNE® therapy causes your skin and eyes to become temporarily sensitive to light. Bring these items with you on the day of your VISUDYNE® treatment appointment:
You should also make arrangements for someone to drive you home after your treatment.
1. You will need to receive an intravenous infusion of VISUDYNE®, usually in your arm, which should take about 10 minutes
2. At the end of the infusion, your doctor will numb your eye with eye drops
3. Fifteen minutes after the infusion begins, the doctor will place a special contact lens on your eye. A laser is then directed through the contact lens onto the affected area of the eye and applied for 83 seconds
4. The laser activates the drug within the abnormal blood vessels to close the blood vessels and stop the leakage
Your skin will be sensitive to bright light and direct sunlight for 5 days after your treatment. After 5 days, you may resume normal outdoor activities without any special precautions.
Be sure to follow all of your doctor's instructions.
Within 3 months, you should have another examination to have pictures of your eyes to show if there is any leakage present. VISUDYNE® therapy usually consists of a series of sessions.
If the pictures show that there is more leakage, additional therapy will be necessary.
this Patient Brochure to learn even more about VISUDYNE®
UPDATE: Click here to order samples for your practice.
VISUDYNE® (verteporfin for injection) is used along with laser light treatment to stop leaking from blood vessels in the eye due to the following serious eye conditions: age-related macular degeneration (a condition affecting the retina of the eye which can impair vision), pathologic myopia (extreme nearsightedness) or ocular histoplasmosis (a certain type of fungus infection in the eye).
You are encouraged to report side effects to the FDA. To report SUSPECTED ADVERSE REACTIONS, contact Bausch + Lomb at 1‑800‑321‑4576 or FDA at 1‑800‑FDA‑1088 or www.fda.gov/medwatch.
Please click here for full Prescribing Information for VISUDYNE®.
Indication and Important Safety Information
VISUDYNE is a registered trademark of Novartis AG used under license. © 2020 Bausch & Lomb Incorporated or its affiliates. VID.0032.USA.20
CALIFORNIA RESIDENTS: DO NOT SELL MY PERSONAL INFORMATION